BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 2532013)

  • 1. A common binding site for tricyclic and nontricyclic 5-hydroxytryptamine uptake inhibitors at the substrate recognition site of the neuronal sodium-dependent 5-hydroxytryptamine transporter.
    Graham D; Esnaud H; Habert E; Langer SZ
    Biochem Pharmacol; 1989 Nov; 38(21):3819-26. PubMed ID: 2532013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction between tricyclic and nontricyclic 5-hydroxytryptamine uptake inhibitors and the presynaptic 5-hydroxytryptamine inhibitory autoreceptors in the rat hypothalamus.
    Galzin AM; Moret C; Verzier B; Langer SZ
    J Pharmacol Exp Ther; 1985 Oct; 235(1):200-11. PubMed ID: 2864432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of [3H]paroxetine binding in rat brain.
    Marcusson JO; Bergström M; Eriksson K; Ross SB
    J Neurochem; 1988 Jun; 50(6):1783-90. PubMed ID: 2967349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissociation kinetics of [3H]paroxetine binding to rat brain consistent with a single-site model of the antidepressant binding/5-hydroxytryptamine uptake site.
    Marcusson J; Eriksson K
    J Neurochem; 1988 Nov; 51(5):1477-81. PubMed ID: 2971784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High affinity binding of [3H]6-nitroquipazine to cortical membranes in the rat: inhibition by 5-hydroxytryptamine and 5-hydroxytryptamine uptake inhibitors.
    Hashimoto K; Goromaru T
    Neuropharmacology; 1991 Feb; 30(2):113-7. PubMed ID: 2030818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct effects of imipramine on 5-hydroxytryptamine uptake mediated by the recombinant rat serotonin transporter SERT1.
    Sur C; Betz H; Schloss P
    J Neurochem; 1998 Jun; 70(6):2545-53. PubMed ID: 9603221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition and dissociation of [3H]-paroxetine binding to human platelets.
    Andersson A; Marcusson J
    Neuropsychobiology; 1989; 22(3):135-40. PubMed ID: 2535005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complex inhibition of [3H]imipramine binding by serotonin and nontricyclic serotonin uptake blockers.
    Sette M; Briley MS; Langer SZ
    J Neurochem; 1983 Mar; 40(3):622-8. PubMed ID: 6827265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temperature dependence of drug interaction with the platelet 5-hydroxytryptamine transporter: a clue to the imipramine selectivity paradox.
    Segonzac A; Schoemaker H; Langer SZ
    J Neurochem; 1987 Feb; 48(2):331-9. PubMed ID: 2947974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional distribution of the serotonin transport complex in human brain, identified with 3H-paroxetine, 3H-citalopram and 3H-imipramine.
    Plenge P; Mellerup ET; Laursen H
    Prog Neuropsychopharmacol Biol Psychiatry; 1990; 14(1):61-72. PubMed ID: 2137251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tryptamine, a substrate for the serotonin transporter in human platelets, modifies the dissociation kinetics of [3H]imipramine binding: possible allosteric interaction.
    Segonzac A; Raisman R; Tateishi T; Schoemaker H; Hicks PE; Langer SZ
    J Neurochem; 1985 Feb; 44(2):349-56. PubMed ID: 3871227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repeated electroconvulsive shock does not change [3H]-paroxetine binding to the 5-HT uptake site in rat cortical membranes.
    Gleiter CH; Nutt DJ
    Psychopharmacology (Berl); 1988; 95(1):68-70. PubMed ID: 2838861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Affinity modulation of [3H]imipramine, [3H]paroxetine and [3H]citalopram binding to the 5-HT transporter from brain and platelets.
    Plenge P; Mellerup ET; Laursen H
    Eur J Pharmacol; 1991 Mar; 206(3):243-50. PubMed ID: 1830276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High- and low-affinity binding of [3H]imipramine in rat hypothalamus.
    Moret C; Briley M
    J Neurochem; 1986 Nov; 47(5):1609-13. PubMed ID: 2944992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High affinity [3H]paroxetine binding to serotonin uptake sites in human brain tissue.
    Bäckström I; Bergström M; Marcusson J
    Brain Res; 1989 May; 486(2):261-8. PubMed ID: 2525060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-site model of the neuronal 5-hydroxytryptamine uptake and imipramine-binding site.
    Marcusson JO; Bäckström IT; Ross SB
    Mol Pharmacol; 1986 Aug; 30(2):121-8. PubMed ID: 3016498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of sodium-dependent [3H]imipramine binding in rat brain by serotonin and serotonin uptake inhibitors.
    Hrdina PD
    Eur J Pharmacol; 1988 Mar; 148(2):279-82. PubMed ID: 3259932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [3H]citalopram binding to brain and platelet membranes of human and rat.
    Plenge P; Mellerup ET
    J Neurochem; 1991 Jan; 56(1):248-52. PubMed ID: 1824783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in the temperature dependence of drug interaction with the noradrenaline and serotonin transporters.
    De Oliveira AM; Schoemaker H; Segonzac A; Langer SZ
    Neuropharmacology; 1989 Aug; 28(8):823-8. PubMed ID: 2528702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Examination of the relationship between the uptake system for 5-hydroxytryptamine and the high-affinity [3H]imipramine binding site--I. Inhibition by drugs.
    Wood MD; Broadhurst AM; Wyllie MG
    Neuropharmacology; 1986 May; 25(5):519-25. PubMed ID: 3016589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.